Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial | Heart Failure | JAMA | JAMA Network

el suplemento de hierro iv a pacientes con insuficiencia cardiaca y saturacion transferrina menor de 20 no redujo la incidencia ni el tiempo de aparicion de eventos.

https://jamanetwork.com/journals/jama/fullarticle/2832132?guestAccessKey=fe6170f6-3e2a-4409-bd26-da669648e0fe&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=033025&adv=000004320864